Care Access - Raleigh

Raleigh, North Carolina 27607

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease, Obesity, Overweight

Studies at this site

• A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight — Running, not enrolling
• A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity — Running, not enrolling
• A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) — Running, not enrolling